CABIRALIZUMAB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where CABIRALIZUMAB was used for Neoplasm malignant.
Most Reported Side Effects for CABIRALIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 5 | 8.2% | 5 | 5 |
| Sepsis | 5 | 8.2% | 5 | 5 |
Other Indications for CABIRALIZUMAB
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)